The page is the record's research on the issuer — no analyst, no rating, no view.

# BriaCell Therapeutics Corp. (NASDAQ: BCTX) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is BriaCell Therapeutics Corp., listed on NASDAQ under ticker BCTX. Its ISIN is US1079303079. Its LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-A1 exists. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is British Columbia, Canada. Its listing status is listed, not halted.

## The disclosure read

The record holds 27 filings across 21 filing days in the window 2025-11-08 to 2026-11-08. Of these, 9 are regulatory filings, 7 are corporate news, 4 are prospectuses, 4 are results, 2 are AGM or EGM filings, and 1 is a halt or suspension. The median gap between filing days is 8.0 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. Days from the latest filing to the record date are 11, against a NASDAQ median of 5.0 days and a sector median of 4.0 days. The latest filing is a results filing dated 2026-10-28. The NASDAQ median filing count is 52 and the sector median is 63.0.

## Auditor

The auditor of record is MNP LLP, located in Toronto, Canada. The record holds no auditor changes.

## Events and halts

The record holds a listing on 2026-01-13 and a delisting on 2026-02-26. The record holds no name change. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

One research house is named on the issuer's own investor-relations page: ThinkEquity.

## Open research

No openly published research notes were found on the record.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The vintage is sealed. The sealed years holding the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001610820.json (identity.jurisdiction)
- https://mcp.us-cm-kg.ai/events/NASDAQ/BCTX (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1610820/000149315226049041/form10-k.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://investors.briacell.com/analyst-coverage (coverage)
- https://mcp.us-cm-kg.ai/record/NASDAQ/BCTX (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/BCTX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
